Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reinfection Rates Among Patients Who Previously Tested Positive for Coronavirus Disease 2019: A Retrospective Cohort Study
Megan Sheehan, Anita Reddy, Michael B. Rothberg
Clinical Infectious Diseases (2021) Vol. 73, Iss. 10, pp. 1882-1886
Open Access | Times Cited: 133

Showing 1-25 of 133 citing articles:

SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity
Stefan Pilz, Verena Theiler‐Schwetz, Christian Trummer, et al.
Environmental Research (2022) Vol. 209, pp. 112911-112911
Open Access | Times Cited: 233
A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies
Srijan Chatterjee, Manojit Bhattacharya, Sagnik Nag, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 167-167
Open Access | Times Cited: 193
SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy
Laith J. Abu‐Raddad, Hiam Chemaitelly, Peter Coyle, et al.
EClinicalMedicine (2021) Vol. 35, pp. 100861-100861
Open Access | Times Cited: 173
Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study
Ariel Israel, Eugene Merzon, Alejandro A. Schäffer, et al.
BMJ (2021), pp. e067873-e067873
Open Access | Times Cited: 150
Correlates of protection from SARS-CoV-2 infection
Florian Krammer
The Lancet (2021) Vol. 397, Iss. 10283, pp. 1421-1423
Open Access | Times Cited: 117
Tixagevimab/cilgavimab pre-exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the omicron wave
Ayman Al Jurdi, Leela Morená, Mariesa Cote, et al.
American Journal of Transplantation (2022) Vol. 22, Iss. 12, pp. 3130-3136
Open Access | Times Cited: 115
Risk of reinfection and disease after SARS‐CoV‐2 primary infection: Meta‐analysis
Maria Elena Flacco, Cecilia Acuti Martellucci, Valentina Baccolini, et al.
European Journal of Clinical Investigation (2022) Vol. 52, Iss. 10
Open Access | Times Cited: 74
Necessity of Coronavirus Disease 2019 (COVID-19) Vaccination in Persons Who Have Already Had COVID-19
Nabin K. Shrestha, Patrick C. Burke, Amy S. Nowacki, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 1, pp. e662-e671
Open Access | Times Cited: 69
Durability of Vaccine-Induced and Natural Immunity Against COVID-19: A Narrative Review
Nick Pooley, Salim S. Abdool Karim, Béhazine Combadière, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 2, pp. 367-387
Open Access | Times Cited: 64
Severity and Outcomes of SARS-CoV-2 Reinfection Compared with Primary Infection: A Systematic Review and Meta-Analysis
Jie Deng, Yirui Ma, Qiao Liu, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 4, pp. 3335-3335
Open Access | Times Cited: 44
Quantifying the risk of SARS‐CoV‐2 reinfection over time
Éamon Ó Murchú, Paula Byrne, Paul G. Carty, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 1
Open Access | Times Cited: 91
A Systematic Review of the Protective Effect of Prior SARS-CoV-2 Infection on Repeat Infection
Noah Kojima, Nabin K. Shrestha, Jeffrey D. Klausner
Evaluation & the Health Professions (2021) Vol. 44, Iss. 4, pp. 327-332
Open Access | Times Cited: 90
Protective immunity after recovery from SARS-CoV-2 infection
Noah Kojima, Jeffrey D. Klausner
The Lancet Infectious Diseases (2021) Vol. 22, Iss. 1, pp. 12-14
Open Access | Times Cited: 90
Equivalency of Protection From Natural Immunity in COVID-19 Recovered Versus Fully Vaccinated Persons: A Systematic Review and Pooled Analysis
Mahesh B. Shenai, Ralph Rahme, Hooman Noorchashm
Cureus (2021)
Open Access | Times Cited: 72
Duration of Severe Acute Respiratory Syndrome Coronavirus 2 Natural Immunity and Protection Against the Delta Variant: A Retrospective Cohort Study
Priscilla Kim, Steven M. Gordon, Megan Sheehan, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 1, pp. e185-e190
Open Access | Times Cited: 64
Protection against Omicron from Vaccination and Previous Infection in a Prison System
Elizabeth T. Chin, David Leidner, Lauren Lamson, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 19, pp. 1770-1782
Open Access | Times Cited: 56
Observed protection against SARS-CoV-2 reinfection following a primary infection: A Danish cohort study among unvaccinated using two years of nationwide PCR-test data
Daniela Michlmayr, Christian Holm Hansen, Sophie Gubbels, et al.
The Lancet Regional Health - Europe (2022) Vol. 20, pp. 100452-100452
Open Access | Times Cited: 52
Risk for Reinfection After SARS-CoV-2: A Living, Rapid Review for American College of Physicians Practice Points on the Role of the Antibody Response in Conferring Immunity Following SARS-CoV-2 Infection
Mark Helfand, Celia Fiordalisi, Jack Wiedrick, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 4, pp. 547-555
Open Access | Times Cited: 49
The prevalence of adaptive immunity to COVID-19 and reinfection after recovery – a comprehensive systematic review and meta-analysis
Tawanda Chivese, Joshua T. Matizanadzo, Omran A. H. Musa, et al.
Pathogens and Global Health (2022) Vol. 116, Iss. 5, pp. 269-281
Open Access | Times Cited: 46
COVID‐19 and plasma cells: Is there long‐lived protection?*
Doan C. Nguyen, Pedro A. Lamothe, Matthew C. Woodruff, et al.
Immunological Reviews (2022) Vol. 309, Iss. 1, pp. 40-63
Open Access | Times Cited: 41
Global prevalence of coronavirus disease 2019 reinfection: a systematic review and meta-analysis
Joyeuse Ukwishaka, Yves Ndayishimiye, Esmeralda Destine, et al.
BMC Public Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 26
Insights from an N3C RECOVER EHR-based cohort study characterizing SARS-CoV-2 reinfections and Long COVID
Emily Hadley, Yun Jae Yoo, Saaya Patel, et al.
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 12
COVID-19 in Children: Expressions of Type I/II/III Interferons, TRIM28, SETDB1, and Endogenous Retroviruses in Mild and Severe Cases
Pier-Angelo Tovo, Silvia Garazzino, Valentina Daprà, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7481-7481
Open Access | Times Cited: 50
Reinfection rates among patients previously infected by SARS-CoV-2: systematic review and meta-analysis
Yinjun Mao, Weiwei Wang, Jun Ma, et al.
Chinese Medical Journal (2021) Vol. 135, Iss. 2, pp. 145-152
Open Access | Times Cited: 45
High rate of reinfection with the SARS-CoV-2 Omicron variant
Nhu Ngoc Nguyen, Linda Houhamdi, Van Thuan Hoang, et al.
Journal of Infection (2022) Vol. 85, Iss. 2, pp. 174-211
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top